Assertion: catalyst | /r/CapableOf | file lawsuit
Facets:
value: in june
type: TEMPORAL
Source sentences:
text: In June 2019, Catalyst filed a lawsuit alleging that the FDA's regulatory decision in May to approve Ruzurgi for pediatric LEMS patients was in part motivated by pricing concerns surrounding Firdapse.